Shares of GeneDx crashed Wednesday after the company reported adjusted earnings of 28 per share on $87.1 million in first-quarter sales.
The post IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise appeared first on Investor's Business Daily.